Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 5,678 | 18,198 | 112,545 | 679 | 408 |
| Gross Profit | 5,678 | 18,198 | 112,545 | 679 | 408 |
| Operating Expenses | 40,359 | 37,830 | 39,146 | 39,413 | 35,237 |
| Operating Income | -34,681 | -19,632 | 73,399 | -38,734 | -34,829 |
| Other Income | 3,356 | 3,002 | 2,116 | 674 | 104 |
| Pre-tax Income | -31,325 | -16,630 | 75,515 | -38,060 | -34,725 |
| Income Tax | 3,616 | 15,028 | 54 | 33 | 32 |
| Net Income Continuous | -34,941 | -31,658 | 75,461 | -38,093 | -34,757 |
| Net Income | $-34,941 | $-31,658 | $75,461 | $-38,093 | $-34,757 |
| EPS Basic Total Ops | -0.83 | -0.75 | 1.80 | -0.91 | -0.83 |
| EPS Basic Continuous Ops | -0.83 | -0.75 | 1.80 | -0.91 | -0.83 |
| EPS Diluted Total Ops | -0.83 | -0.66 | 1.71 | -0.91 | -0.83 |
| EPS Diluted Continuous Ops | -0.83 | -0.66 | 1.71 | -0.91 | -0.83 |
| EBITDA(a) | $-36,079 | $-20,677 | $73,116 | $-38,198 | $-34,292 |